Heron Therapeutics Inc (HRTX)

Operating Cash Flow Growth

58.77%

TTM · Period ending:

HRTX logo

HRTX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported58.77%
HRTX TTM Cash from Operations YoY % (23.53% → 58.77%)
High-resolution chart · PNG

HRTX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Heron Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
58.7665%
7.4121%
-22.4688%
-263.9619%
-35.0365%
49.5841%
61.6782%
91.6034%
83.544%
66.0562%
59.9835%
36.1222%
25.8124%
37.7308%
27.7555%
26.591%
14.4343%
-5.9498%
-10.0281%
-32.2821%
-39.8696%
-78.6535%
-48.3545%
-21.4761%
-0.8234%
39.4298%
35.0486%
36.199%
32.6634%
1.2765%
-12.6277%
-27.0888%
-33.6312%
-19.1069%
-26.9976%
-36.1724%
-53.4132%
-67.0106%
-70.7676%
-74.0009%
-51.6684%
-41.9845%
-30.2644%
-19.5979%
-34.704%
-32.4085%
-47.8841%
-53.1145%
-81.0342%
-132.5409%
-139.6555%
-178.9206%
-109.7722%
-93.1044%
-120.2953%
-116.6559%
-114.2556%
-67.6078%
-40.8171%
6.0491%
-0.9%
19.3141%
50.15%
56.3572%
65.6705%
60.7632%
54.69%
33.4425%
22.1474%
-12.5166%
-40.4722%
-40.8867%
-58.6195%
-3.9582%
-288.2257%
-257.0561%
-217.5104%
-218.5359%
221.9742%
243.3123%
276.529%
291.4103%
2.7896%
7.0207%
2.6887%
-16.26%
-18.6667%
-25.2329%
-10.5247%
-17.8455%
-27.1682%
0.2079%
5.1484%
11.8363%
20.9542%
-5.3242%
-41.0195%
-40.5587%
-108.3173%
-745.3915%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.